Fávero Vanraes Larissa, Beckers Veerle, Van Berkel Kim, Gucciardo Leonardo, Faron Gilles
Department of Gynaecology and Obstetrics, Vrije Universiteit Brussel, Brussels Health Campus, Brussels, Belgium.
Division of Haematology, Department of Internal Medicine, Vrije Universiteit Brussel, Brussels Health Campus, Brussels, Belgium.
Case Rep Perinat Med. 2022 Mar 4;11(1):20210004. doi: 10.1515/crpm-2021-0004. eCollection 2022 Jan.
Haemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disorder of the immune system that typically occurs in the paediatric population. Diagnosing this rare disease in the adult population is challenging, particularly during pregnancy.
We present a case of a gravid patient developing HLH at week 13 of gestation undergoing a medical termination of pregnancy at 27 weeks due to anhydramnios and associated stopped foetal growth.
Disease triggers could vary from a simple viral infection to the pregnancy as such causing the disorder. Treatment should benefit the mother and limit the foetal harm.
噬血细胞性淋巴组织细胞增生症（HLH）是一种潜在致命的免疫系统疾病，通常发生于儿科人群。在成人中诊断这种罕见疾病具有挑战性，尤其是在孕期。
我们报告一例妊娠患者，在妊娠13周时发生HLH，因羊水过少及相关胎儿生长停止，于27周时接受了人工流产。
疾病触发因素可能从简单的病毒感染到妊娠本身引发该疾病。治疗应使母亲受益并减少对胎儿的伤害。
